Table 3.
25(OH) Vitamin D levels at admission and at 6-month follow-up visit in the entire study cohort subdivided by presence of long COVID and of specific alterations in each affected clinical area
| 25(OH) vitamin D levels at admission (ng/mL) | P value | ||
|---|---|---|---|
| Long COVID, yes/no | Yes (n = 50): 13 (9-21) | No (n = 50): 15.8 (9.9-25) | .41 |
| Senses area, yes/no | Yes (n = 18): 12.1 (8-17.5) | No (n = 82): 15.5 (9.8-25.5) | .12 |
| Constitutional, yes/no | Yes (n = 21): 13.2 (9.3-36) | No (n = 79): 15.1 (9.2-21) | .57 |
| Cardiorespiratory, yes/no | Yes (n = 21): 14.3 (9.2-21) | No (n = 79): 16.1 (9.8-25.8) | .63 |
| Gastrointestinal, yes/no | Yes (n = 2): 13.8 (11.6-13.8) | No (n = 98): 14.7 (9.1-22) | .82 |
| Neurocognitive, yes/no | Yes (n = 7): 9.1 (7.1-11.7) | No (n = 93): 15.3 (10.3-23.4) | .03 |
| Ear nose and throat, yes/no | Yes (n = 6): 13 (9.1-21.4) | No (n = 94): 19 (16-29.5) | .12 |
| 25(OH) Vitamin D levels at 6-month follow-up (ng/mL) | |||
| Long COVID, yes/no | Yes (n = 50): 20.1 (13.6-22) | No (n = 50): 23.2 (16.7-26.6) | .03 |
| Senses area, yes/no | Yes (n = 18): 18.4 (14-21.5) | No (n = 82): 20.7 (15.1-29) | .15 |
| Constitutional, yes/no | Yes (n = 21): 20 (12-26) | No (n = 79): 20.8 (15.3-25) | .41 |
| Cardiorespiratory, yes/no | Yes (n = 21): 20.4 (15-26) | No (n = 79): 20.6 (14-22) | .68 |
| Gastrointestinal, yes/no | Yes (n = 2): 16.2 (12-16.2) | No (n = 98): 20.6 (15.2-25) | .38 |
| Neurocognitive, yes/no | Yes (n = 7): 14.6 (12.6-21.2) | No (n = 93): 20.6 (15.3-25.6) | .042 |
| Ear nose and throat, yes/no | Yes (n = 6): 20.9 (18-22.1) | No (n = 94): 20.4 (14-25.5) | .81 |
P values in bold are statistically significant.